LivaNova PLC risk profile

39 Normal where most of the sector sits

Measured 21 October 2026 from LIVN's filed statements. Recomputed nightly.

39 (Normal), driven by Concentration at 51, over 6 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation30NormalStableOne-year price volatility — 36.0%
Operating pressure19ContainedStableCosts outgrowing revenue — -2.4 percentage points
Cash conversion26NormalWorseningCapital spending against operating cash — 0.32x
Leverage and coverage46ElevatedWorseningInterest cover — -2.27x
Competitive position46ElevatedStableOperating-margin gap against peers — +6.8 percentage points
Concentration51ElevatedStableGeographic concentration — 3,962 HHI

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for LivaNova PLC